Drug development

Long-awaited Commission proposals to reform EU’s pharmaceutical legislation seek to improve access to medicines and promote innovation, but companies say they will drive investment out of Europe

Already overdue, the new pharmaceutical strategy will not be published tomorrow as promised. The Commission says the proposal will arrive ‘slightly later’, as tensions fly high over how to incentivise industrial R&D

The latest figures on R&D funding for neglected diseases show the EU is making its greatest contribution to date. But looking at the big picture it’s clear more needs to be done to tackle diseases that affect millions of people around the world